Home Pharma China Web Edition Pharma China Archives Online Databases Subscription/Order/Info Event Calendar China Pharma Providers About Us
Location: Home > Pharma China Web Edition    
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor´s Picks
 
 
WiCON International Group
311 Sayre Drive,
Princeton, NJ 08540, USA
Tel/Fax: +1 702-9953905
Email:
info@pharmachinaonline.com

China Head Office
c/o Beijing Jicai PharmTech
Suite B-17D, Oriental Kenzo Plaza
48 Dongzhimenwai Dajie
Dongcheng District
Beijing 100027, China
Tel: +86 10 84476010
Fax: +86 10 84476010
Email:
info@pharmachinaonline.com
 
 
 
News
 
Novotech: Asia-Pacific Had A Record Year for Clinical Trials 1/20/2020
Chi-Med Reports Positive Surufatinib Phase III SANET-p Study (free) 1/20/2020
Zydus and CMS enter into a License Agreement for Desidustat in Gr... 1/20/2020
China-Based Ivy Capital Invests in Betagenon's Clinical Stage AMP... 1/20/2020
National Primary Healthcare Working Conference Highlights Key Tas... 1/20/2020
National Drug Registration and Post-marketing Surveillance Confer... 1/20/2020
NMPA Publicizes List of Reference Formulations for Generic Drug E... 1/20/2020
I-Mab Biopharma Nabs $104M from Nasdaq IPO 1/17/2020
Hengrui's Billionaire Founder Retires into the Backseat 1/17/2020
Round 2 of the National Level Centralized Drug Purchase Program C... 1/17/2020
Chinese Pharmaceutical Industry Growth Continued to Slow in 2019 1/17/2020
More>>
 
Feature Articles
 
Bayer to Focus More on R&D and Innovation in China 1/20/2020
US, China Sign Phase One Trade Deal: How to Read the Agreement 1/17/2020
Drugmakers Brace for China's Biggest-Ever Round of Price Cuts 1/16/2020
Boehringer Ingelheim's Bet on Chinese CDMO Market Pays Off with B... (free) 1/6/2020
Chinese Scientist Extradited to Stand Trial in the US for Plot to... 1/6/2020
Meeting Clinical Trial Data Requirements In Asian Markets 1/3/2020
U.S.-China Phase I Trade Deal - An Opportunity Window MNCs Must N... 1/2/2020
Recent Announcement for A More Effective Intellectual Property Pr... 12/19/2019
Takeda Aspires to Become A Top Ten MNC Pharma Co. in China 12/18/2019
A Few Details on the US-China "Phase One" Trade Deal 12/16/2019
The US-China Trade Deal Phase Two - Digital Trade, IP, Cyber Intr... 12/16/2019
More>>
 
 
 
 
© Wicon International Group  Support by: www.heightow.com   Site map | Contact Us | Links